This single-center retrospective cohort included 638 adults undergoing 671 peripheral V-A/V-AV ECMO episodes during 2021–2025. Intracardiac thrombus was detected in 58 episodes (8.6%). Higher LVEF, higher day-1 pulse pressure, and systemic heparinization were associated with lower thrombus hazard: adjusted hazard ratios were 0.98 per percentage-point increase (95% CI 0.96–1.00), 0.98 per mmHg increase (95% CI 0.96–1.00), and 0.20 (95% CI 0.11–0.39), respectively. The LVEF association was nonlinear, with risk increasing sharply below approximately 35%, whereas the pulse-pressure association was linear.
These associations may help characterize intracardiac thrombosis risk during peripheral V-A/V-AV ECMO, but they do not establish that modifying pulsatility or anticoagulation prevents thrombosis.
Study limitation: The single-center retrospective design limits generalizability and cannot establish causal effects of anticoagulation or haemodynamic factors.
AI-generated from the published abstract with automated source checks. For research discovery; consult the original paper before applying findings.